Abstract

Helicobacter pylori was classified by the World Health Organization as a class 1 carcinogen. The development of drug-resistant strains of this pathogen poses a serious threat to human health worldwide. The cell invasion of H. pylori activates xenophagy in gastric epithelial cells by mediating miR-30b/c, and the emergence of autophagosomes provides a niche that enables the survival of intracellular H. pylori and promotes its drug resistance. This study revealed that some clinical drug-resistant H. pylori strains present much stronger invasive ability than standard strains. Patchouli alcohol (PA), a tricyclic sesquiterpene from Pogostemon cablin (Blanco) Benth (Labiatae), showed reliable activity against intracellular H. pylori. The mechanisms appeared to involve the downregulation of miR-30c-3p/5p and miR-30b-5p, thereby upregulating xenophagy-related gene expression (ULK1, ATG5, ATG12, and ATG14) and enhancing xenophagy. PA also inhibited the nuclear transfection of miR-30b-5p induced by H. pylori, thereby enhancing transcription factor EB function and increasing lysosome activity. The finding of strongly invasive intracellular H. pylori has great implications for clinical treatment, and PA can act against invasive H. pylori based on the improvement of miR-30b/c mediated xenophagy. Taken together, the results demonstrate that PA have potential use as a candidate medication for intracellular drug-resistant H. pylori.

Highlights

  • Helicobacter pylori was classified by the World Health Organization as a class 1 carcinogen, infecting half of the world’s population (Ferrero et al, 2012)

  • The intracellular/extracellular bacterial ratios obtained indicate that some clinical strains show stronger cell invasive ability than standard strains

  • Patchouli alcohol (PA) Ameliorates the Effects of H. pylori Infection and the Intracellular H. pylori Burden on GES-1 and MKN45 Cells

Read more

Summary

Introduction

Helicobacter pylori was classified by the World Health Organization as a class 1 carcinogen, infecting half of the world’s population (Ferrero et al, 2012). H. pylori plays a major role in gastric ulcer, atrophic gastritis, and gastric carcinoma. Triple therapy (a proton pump inhibitor combined with two antibiotics, like clarithromycin [CLR], metronidazole [MTZ]) are adopted to treat the infection, the increasing drug-resistant rate of H. pylori definitely undermine the efficacy of eradication treatment. The infection process of H. pylori is fairly complex. The bacteria penetrate the gastric mucosa via its flagella and chemotaxis protein (Lertsethtakarn et al, 2011).

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.